Hubei Jianxiang Bioscience: difference between revisions
Diff·revision 11 → 12·22:36, 13 Aug 2025
Difference between revision 11 and revision 12 of Hubei Jianxiang Bioscience. 4 lines changed; the page grew by 489 bytes.
| Revision 11 — 18:30, 29 Jul 2025 ArchiveBot (talk) bot: update parent category chain 8,047 bytes +421 | Revision 12 — 22:36, 13 Aug 2025 Chromatokid (talk) rm the price; supplier articles carry no price per PP:VN 8,536 bytes +489 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Dispatch address versus registered address}} | |
| 21 | 22 | ||
| 22 | '''Hubei Jianxiang Bioscience Co., Ltd.''' (trading as '''HJ'''; hubeijianxiang.net) is a research-compound supplier trading as HJ from Xianning, Hubei, China, incorporated in 2015, supplying research peptides and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} | 23 | '''Hubei Jianxiang Bioscience Co., Ltd.''' (trading as '''HJ'''; hubeijianxiang.net) is a research-compound supplier trading as HJ from Xianning, Hubei, China, incorporated in 2015, supplying research peptides and raw materials with batch documentation and tracked shipping.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 61 | Minimum order quantity is a single vial on listed items. | 62 | Minimum order quantity is a single vial on listed items. |
| 62 | 63 | ||
| + | 64 | The certificate names the lot, the compound and the release date and reports both [[Area percent purity|area percent]] purity and [[Peptide content|peptide content]], which is the pairing that makes a purity figure interpretable as a mass.{{r|usp1503}} Submissions describe the incretin-line documentation as itemised by individual impurity rather than reported as an aggregate. | |
| + | 65 | ||
| 63 | == References == | 66 | == References == |
| 64 | {{reflist}} | 67 | {{reflist}} |
| ⋮ | ⋮ | ||
| 76 | * [[Peptide content]] | 79 | * [[Peptide content]] |
| 77 | * [[Research use only]] | 80 | * [[Research use only]] |
| + | 81 | * [[Peptide supply chain]] | |
| 78 | 82 | ||
| 79 | {{DEFAULTSORT:Hubei Jianxiang Bioscience}} | 83 | {{DEFAULTSORT:Hubei Jianxiang Bioscience}} |